Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 2	2026-09-18		NCT07340541

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Advanced Research Projects Agency for Health (ARPA-H)	9
Breast Cancer Research Foundation	40
Translational Breast Cancer Research Consortium	19
UNC Lineberger Comprehensive Cancer Center	125

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor College of Medicine	Houston	United States	306
Johns Hopkins University/Sidney Kimmel Cancer Center	Baltimore	United States	238
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill	Chapel Hill	United States	1
Mayo Clinic	Rochester	United States	664
University of Pennsylvania/Abramson Cancer Center	Philadelphia	United States	118
Yale Cancer Center Clinical Trials Office	New Haven	United States	1